EricMarkHorwitzMDFABS, FASTRO(He/Him)

PubMed

• 97 citations
  The evolution of brachytherapy for prostate cancer.
  Nicholas G. Zaorsky, Brian J. Davis, Paul L. Nguyen, Timothy N. Showalter, Peter Hoskin
  Nature Reviews. Urology. 2017-06-30
• 54 citations
  Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the Internationa...
  Robert T. Dess, Krithika Suresh, Michael J. Zelefsky, Stephen J. Freedland, Brandon A. Mahal
  JAMA Oncology. 2020-12-01
• 52 citations
  What Are Medical Students in the United States Learning About Radiation Oncology? Results of a Multi-Institutional Survey.
  Nicholas G. Zaorsky, Talha Shaikh, Elizabeth Handorf, Gary Eastwick, Adam A. Hesney
  International Journal of Radiation Oncology, Biology, Physics. 2016-02-01

Journal Articles

• Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results from the Internationa...  
  Michael J Zelefsky, Matthew R Cooperberg, Brian J Davis, Eric M Horwitz, Martha K Terris, Christopher L Amling, Christopher J Kane, Curtiland Deville, Theodore L Dewee..., JAMA Oncology
• Institutional clinical trial accrual volume and survival of patients with head and neck cancer  
  Wuthrick, E.J.; Zhang, Q.; Machtay, M.; Rosenthal, D.I.; Nguyen-Tan, P.F.; Fortin, A.; Silverman, C.L.; Raben, A.; Kim, H.E.; Horwitz, E.M.; Read, N.E.; Harris, J.; Wu..., J Clin Oncol, 1/1/2015
• Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer  
  Martin, J.M.; Handorf, E.A.; Price, R.A.; Cherian, G.; Buyyounouski, M.K.; Chen, D.Y.; Kutikov, A.; Johnson, M.E.; Ma, C. M.; Horwitz, E.M., Med Dosim, 1/1/2015
• Nadir Testosterone Within First Year of Androgen-Deprivation Therapy (ADT) Predicts for Time to Castration-Resistant Progression: A Secondary Analysis of the PR-7 Tria...  
  Klotz, L, O'Callaghan, C, Ding, K, Toren, P, Dearnaley, D, Higano, CS, Horwitz, E.M., Malone, S, Goldenberg, L, Gospodarowicz, M, Crook, JM, J Clin Oncol, 1/1/2015
• SU-E-T-747: The Use of the EQD2 Formalism and Repair Estimates in the Re-Irradiation Setting and Correlation with Patient Follow-Up Data  
  Price, R., Meyer, J., Horwitz, EM., Ma, C., Med Phys, 1/1/2015
• Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer  
  Wang, L.S., Murphy, C.T., Ruth, K., Zaorsky, N.G., Smaldone, M. C., Sobczak, M.L., Kutikov, A., Viterbo, R., Horwitz, E.M., Cancer, 1/1/2015
• Use of Postprostatectomy Radiation Therapy at an NCI-Designated Comprehensive Cancer Center  
  Martin, J.M., Li, T., Johnson, M.E., Murphy, C.T., Howald, A.G., Smaldone, M.C., Kutikov, A., Chen, D.Y., Viterbo, R., Greenberg, R.E., Uzzo, R.G., Horwitz, E.M., J Natl Compr Canc Netw, 1/1/2015
• Post-radiotherapy prostate biopsies reveal heightened apex positivity relative to other prostate regions sampled  
  Huang, K.T., Stoyanova, R., Walker, G., Sandler, K., Studenski, M.T., Dogan, N., Al-Saleem, T., Buyyounouski, M.K., Horwitz, E.M., Pollack, A., Radiother Oncol, 1/1/2015
• Does family history of prostate cancer affect outcomes following radiotherapy?  
  Bagshaw, H.; Ruth, K.; Horwitz, E.M.; Chen, D. Y.; Buyyounouski, M. K., Radiother. Oncol., 1/1/2014
• Reply to MJ Brenner et al and IR Vogelius et al  
  Pollack, A.; Walker, G.; Horwitz, E.M.; Price, R.; Feigenberg, S.; Konski, A. A.; Stoyanova, R.; Movsas, B.; Greenberg, R. E.; Uzzo, R. G.; Ma, C.; Buyyounouski, M. K., J. Clin. Oncol., 1/1/2014
• Prostate cancer, version 22014  
  Mohler, J. L.; Kantoff, P. W.; Armstrong, A. J.; Bahnson, R. R.; Cohen, M.; D'Amico, A. V.; Eastham, J. A.; Enke, C. ; A.; Farrington, T. A.; Higano, C. S.; Horwitz, E..., J Natl Compr Canc Netw, 1/1/2014
• Medicare physician payment data: Is this transparency?  
  Horwitz, E.M. and Weinberg, D.S., Ann. Int. Med., 1/1/2014
• Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with mode...  
  Murphy, C.T.; Heller, S.; Ruth, K.; Buyyounouski, M.K.; Weinberg, D.; Uzzo, R.G.; Plimack, E.; Kutikov, A.; Chen, D.Y.; Horwitz, E.M., Practical Radiation Oncology, 1/1/2014
• Is it necessary to perform week three dosimetric analysis in low-dose rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment  
  Shaikh, T.; Zaorsky, N. G.; Ruth, K.; Chen, D.Y.; Greenberg, R.E.; Li, J.; Crawford, K.; Horwitz, E.M., Brachytherapy, 1/1/2014
• Reduction of prostate intrafractional motion from shortening the treatment time  
  Li, J.; Lin, M.-H.; Buyyounouski, M.K.; Horwitz, E.M.; Ma, C.-M., Phys. Med. Biol., 1/1/2013
• A Novel Method for Predicting Late Genitourinary Toxicity After Prostate Radiation Therapy and the Need for Age-Based Risk-Adapted Dose Constraints  
  Ahmed, A.A.; Egleston, B.; Alcantara, P.; Li, L.N.; Pollack, A.; Horwitz, E.M.; Buyyounouski, M.K., International Journal of Radiation Oncology Biology Physics, 1/1/2013
• In reply to Cheung  
  Turaka, A.; Buyyounouski, M.K.; Horwitz, E.M.; Movsas, B., Oncol Biol Phys, 1/1/2013
• Seminal Vesicle Target Delineation for Intermediate-Risk Prostate Cancer IMRT  
  Johnson, M. E.; Ruth, K.; Buyyounouski, M. K.; Horwitz, E.M., Pract. Radiat. Oncol., 1/1/2013
• ABS brachytherapy consensus guidelines  
  Horwitz EM, Brachytherapy, 1/1/2012
• American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy  
  Davis BJ, Horwitz EM, Lee WR, Crook, J. M.; Stock, R. G.; Merrick, G. S.; Butler, W. M.; Grimm, P. D.; Stone, N. N.; Potters, L.; Zietman, A. L.; Zelefsky, M. J., Brachytherapy, 1/1/2012
• Biochemical and clinical experience with real-time intraoperatively planned permanent prostate brachytherapy  
  Lubbe, W.; Cohen, R.; Sharma, N.; Ruth, K.; Peters, R.; Li, J.; Buyyounouski, M.K.; Kutikov, A.; Chen, D.Y.; Uzzo, R.G.; Horwitz, E.M., Brachytherapy, 1/1/2012
• A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 update  
  Buyyounouski, MK.; Davis, B.J.; Prestidge, B.R.; Shanahan, T.G.; Stock, R.G.; Grimm, P.D.; Demanes, D.J.; Zaider, M.; Horwitz, E.M., Brachytherapy, 1/1/2012
• Intermittent androgen suppression for rising PSA level after radiotherapy  
  Crook, J.M.; O'Callaghan, C.J.; Duncan, G.; Dearnaley, D.P.; Higano, C.S.; Horwitz, E.M.; Frymire, E.; Malone, S.; Chin, J.; Nabid, A.; Warde, P.; Corbett, T.; Angyalf..., New England Journal of Medicine, 1/1/2012
• Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy  
  Zaorsky, N.G.; Buyyounouski, M.K.; Li T.; Horwitz, E.M., International Journal of Radiation Oncology Biology Physics, 1/1/2012
• Prostate Bed Motion during Intensity-Modulated Radiotherapy Treatment  
  Klayton, T.; Price, R.; Buyyounouski, M.K.; Sobczak, M.; Greenberg, R.E.; Li, J.; Keller, L.; Sopka, D.; Kutikov, A.; Horwitz, E.M., International Journal of Radiation Oncology Biology Physics, 1/1/2012
• Join now to see all

Books/Book Chapters

• Image-Guided Radiation Therapy: A Clinical Perspective 
  Chapter: MR-guided target delineation in a patient with prostate cancer. 
  Buyyounouski, M.K. and Horwitz, E.M.Editors: Mundt, A.J. and Roeske, J..People's Medical Publishing House, Shelton, CT2011
• Comprehensive Textbook of Genitourinary Oncology 
  Chapter: Recurrence following Radiotherapy: Definitions, Prognosis and Management. 
  Horwitz, E.M.Editors: Vogelzang, N.J.; Scardino, P.T.; Zelefsky, M.J.; and Linehan, W.M. with Rini, B.I.; Bochner, B.H. and Sheinfeld, J..Lippincott, Williams, & Wilkins, Philadelphia, PAEdition 4th,2010
• Handbook of Radiation Oncol-Basic Principles and Clinical Protocols 
  Chapter: Prostate Cancer. 
  Page 565 - 582Buyyounouski, M.K.; Horwitz, E.M.; Pollack, A.Editors: Haffty, B. and Wilson, L.D..Jones and Bartlett Publishers, Sudbury, MA2009
• Prostate Cancer: Principles and Practices of Image-guided Radiation Therapy 
  Chapter: IGRT in prostate cancer: focus on BAT ultrasound. 
  Page 103 - 112Silverman, J.S. and Horwitz, E.M.Editors: Valicenti, R.K., Dicker, A.P., and Jaffray, D.A..Informa Healthcare USA, Inc., NY, NY2008
• Prostate Cancer-Principles and Practice 
  Chapter: Initial management of high risk early stage prostate cancer: Radiation. 
  Page 855 - 863Horwitz, E.M.; Feigenberg, S.J.; Pollack, A.Editors: Kirby, R.S., Partin, A.W., Feneley, M., and Parsons, J.K..Taylor & Francis, Boca Raton2006
• Intensity Modulated Radiation Therapy: A Clinical Perspective 
  Chapter: Intact prostate cancer: Overview 
  Page 436 - 448Pollack, A.; Price, R.A.; Dong, L.; Feigenberg, S.J.; Horwitz, E.M.Editors: AJ Mundt and JC Roeske.BC Decker, Inc, ON, Canada2005
• Intensity Modulated Radiation Therapy: A Clinical Perspective 
  Chapter: Intact prostate cancer: Case Study. 
  Page 459 - 463Price, R.A.; Horwitz, E.M.; Feigenberg, S.J.; Pollack, A.Editors: AJ Mundt and JC Roeske.BC Decker, Inc, ON, Canada2005
• Cancer Management: A Multidisciplinary Approach 
  Chapter: Head and neck tumors. 
  Page 37 - 78Ridge, J.A.; Glisson, B.S.; Horwitz, E.M.; Meyers, M.; and Fein, D.A.Editors: Pazdur, R., Coia, L.R., Hoskins, W.J., and Wagman, L.D..PRR, Huntington, NY2002
• Advanced Therapy Of Prostatic Disease 
  Chapter: T3-T4NxM0: The case for radiotherapy. 
  Page 284 - 290Horwitz, E.M. and Hanks, G.E.Editors: Resnick, M.I. and Thompson, I.M..B.C. Decker, Inc., Hamilton1999
• Comprehensive Textbook Of Genitourinary Oncology 
  Chapter: Hormonal therapy combined with radiation or surgery in the treatment of locally advanced non-metastatic prostate cancer. 
  Horwitz, E.M. and Hanks, G.E.Editors: Vogelzang, N.J., Scardino, P.T., Shipley, W.U., and Coffey, D.S..Lippincott, Williams, & Wilkins, Baltimore1999
• Current Clinical Oncology: Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done 
  Chapter: Tumor resistance to apoptosis. 
  Uzzo, R.G.; Cairns, P.; Dulin, N.; Horwitz, E.M.; Pollack, A.; Kolenko, V.Editors: Finke, J.H. and Bukowski, R.M..Humana Press Inc., Totowa, NJ
• Join now to see all

Abstracts/Posters

• The Role of Adjuvant and Salvage Post-Prostatectomy IMRT or 3DCRT: The Fox Chase Experience.
  Horwitz, E.M.; Sharma, N.K.; Ruth, K.J.; Silverman, J.S.; Buyyounouski, M.K.; Chen, D.Y.T.; Greenberg, R.E.; Uzzo, R.G., 52nd Annual Meeting of the American Society of Radiation Oncology, San Diego, CA, 1/31/2010
• The Role of Adjuvant and Salvage Post-Prostatectomy IMRT or 3DCRT: The Fox Chase Experience.
  Horwitz, E.M.; Sharma, N.K.; Ruth, K.J.; Silverman, J.S.; Buyyounouski, M.K.; Chen, D.Y.T.; Greenberg, R.E.; Uzzo, R.G., International Journal of Radiation Oncology Biology and Physics, 1/1/2010
• Undetectable Post-Treatment PSA Following 3DCRT or IMRT Alone For Patients with Low or Intermediate Risk Prostate Cancer Is an Independent Predictor of Biochemical and...
  Horwitz, E.M.; Ruth, K.; Sharma, N.K.; Chen, D.Y.T.; Buyyounouski, M.K.; Uzzo, R.G., 51st Annual Meeting of the American Society of Radiation Oncology, Chicago, IL, 1/1/2009
• Undetectable Post-Treatment PSA Following 3DCRT or IMRT Alone For Patients with Low or Intermediate Risk Prostate Cancer Is an Independent Predictor of Biochemical and...
  Horwitz, E.M.; Ruth, K.J.; Sharma, N.K.; Chen, D.Y.T.; Buyyounouski, M.K.; Uzzo, R.G., International Journal of Radiation Oncology Biology and Physics, 1/1/2009
• PSA Doubling Time Predicts for the Development of Distant Metastases for Patients Who Fail 3DCRT Or IMRT ssing The Phoenix Definition.
  Horwitz, E.M.; Ruth, K.; Uzzo, R.G.; Buyyounouski, M.K.; Wong, Y.-N.; Chen, D.Y.T.; Pollack, A., 50th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Boston, MA, 1/21/2008
• PSA Doubling Time Predicts For The Development Of Distant Metastases For Patients Who Fail 3DCRT or IMRT Using The Phoenix Definition.
  Horwitz, E.M.; Ruth, K.; Uzzo, R.G.; Buyyounouski, M.K.; Wong, Y.-N.; Chen, D.Y.T.; Pollack, A., International Journal of Radiation Oncology Biology and Physics, 1/1/2008
• The Phoenix Definition of Biochemical Failure Correlates With Clinical Failure For Men Treated With Adjuvant And Salvage Post-Prostatectomy Radiation: Results of the M...
  Horwitz, E.M.; Hanlon, A.L.; Pisansky, T.M.; Sandler, H.M.; Kuban, D.A.; Catton, C.; Michalski, J.M.; Stephenson, A.; Pollack, A.; and the Post-Prostatectomy Radiation..., 49th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Los Angeles, CA, 1/28/2007
• The Phoenix definition of biochemical failure correlates with clinical failure for men treated with adjuvant and salvage post-prostatectomy radiation: Results of the m...
  Horwitz, E.M.; Hanlon, A.L.; Pisansky, T.M.; Sandler, H.M.; Kuban, D.A.; Catton, C.; Michalski, J.M.; Stephenson, A.; Pollack, A. and the Post-Prostatectomy Radiation ..., International Journal of Radiation Oncology Biology and Physics, 1/1/2007
• The Post-Treatment PSA Bounce for Prostate Cancer Patients Treated With External Beam RT or Permanent Brachytherapy Alone Is Not Biochemically or Clinically Significan...
  Horwitz, E.M.; Levy, L.B.; Martinez, A.A.; Potters, L.; Beyer, D.C.; Blasko, J.C.; Sandler, H.M.; Buskirk, S.J.; Zietman, A.L.; Kuban, D.A., 48th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Philadelphia, PA, 1/4/2006
• The Post-Treatment PSA Bounce for Prostate Cancer Patients Treated With External Beam RT or Permanent Brachytherapy Alone Is Not Biochemically or Clinically Significan...
  Horwitz, E.M.; Levy, L.B.; Martinez, A.A.; Potters, L.; Beyer, D.C.; Blasko, J.C.; Sandler, H.M.; Buskirk, S.J.; Zietman, A.L.; Kuban, D.A., International Journal of Radiation Oncology Biology and Physics, 1/1/2006
• Phase II Study Of Paclitaxel & Cisplatin In Combination With Split Course Concomitant Hyperfractionated Re-Irradiation In Patients With Recurrent Squamous Cell Cancer ...
  Horwitz, E.M.; Harris, J.; Langer, C.J.; Nicolaou, N.; Kies, M.; Curran, W.J.; Wong, S.J.; Ang, K.K., 47th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Denver, CO, 1/16/2005
• Treatment with TNF-a and TPEN decreases NF-kB activity and induces apoptosis in PC-3 cells.
  Crispen PL.; Golovine C.; Makhov P.; Pollack A.; Horwitz E.M.; Greenberg RE.; Uzzo R.; Kolenko V, Proceedings of the Society of Urologic Oncology, 1/1/2005
• Concurrent Split Course Hyperfractionated Radiotherapy (Hfx RT), Cisplatin (DDP) and Paclitaxel (P) in Patients with Recurrent, Previously Irradiated Squamous Cell Car...
  Horwitz, E.M.; Harris, J.; Langer, C.J.; Nicolaou, N.; Kies, M.; Curran, W.J.; Wong, S.J.; Ang, K.K., Proceedings of the American Society of Clinical Oncology, 1/1/2005
• Phase II Study Of Paclitaxel & Cisplatin In Combination With Split Course Concomitant Hyperfractionated Re-Irradiation In Patients With Recurrent Squamous Cell Cancer ...
  Horwitz, E.M.; Harris, J.; Langer, C.J.; Nicolaou, N.; Kies, M.; Curran, W.J.; Wong, S.J.; Ang, K.K., International Journal of Radiation Oncology Biology and Physics, 1/1/2005
• Phase II Study Of Paclitaxel, Cisplatin In Combination With Split Course Concomitant Hyperfractionated Re-Irradiation In Patients With Recurrent Squamous Cell Cancer O...
  Horwitz, E.M.; Harris, J.; Langer, C.J.; Nicolaou, N.; Kies, M.; Curran, W.J.; Wong, S.J.; Ang, K.K., 6th International Head and Neck Meeting, Washington, DC, 1/8/2004
• The Biochemical And Clinical Significance Of The Post-Treatment PSA Bounce For Prostate Cancer Patients Treated With External Beam Radiation Therapy Alone: A Multi-Ins...
  Horwitz, E.M.; Levy, L.B.; Thames, H.D.; Kuban, D.A.; Kupelian, P.A.; Martinez, A.A.; Michalski, J.M.; Pisansky T.M.; Sandler, H.M.; Shipley, W.U.; Zelefsky, M.J.; Han..., 46th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Atlanta, GA, 1/3/2004
• Phase II Study Of Paclitaxel, Cisplatin In Combination With Split Course Concomitant Hyperfractionated Re-Irradiation In Patients With Recurrent Squamous Cell Cancer O...
  Horwitz, E.M.; Harris, J.; Langer, C.J.; Nicolaou, N.; Kies, M.; Curran, W.J.; Wong, S.J.; Ang, K.K., Proceedings of the 6th International Head and Neck Meeting, 1/1/2004
• The Biochemical And Clinical Significance Of The Post-Treatment PSA Bounce For Prostate Cancer Patients Treated With External Beam Radiation Therapy Alone: A Multi-Ins...
  Horwitz, E.M.; Levy, L.B.; Thames, H.D.; Kuban, D.A.; Kupelian, P.A.; Martinez, A.A.; Michalski, J.M.; Pisansky T.M.; Sandler, H.M.; Shipley, W.U.; Zelefsky, M.J.; Han..., International Journal of Radiation Oncology Biology and Physics, 1/1/2004
• Using MRI-simulation to define radiation dose to the penile bulb and corporal bodies for prostate cancer patients treated with intensity modulated radiation therapy or...
  Horwitz, E.M.; Buyyounouski, M.K.; Uzzo, R.G.; Price, R.A.; McNeeley, S.W.; Aziz, D.; Hanlon, A.L.; Milestone, B.N.; Pollack, A., 85th Annual Meeting of the American Radium Society, Houston, TX, 1/26/2003
• Definitions Of Biochemical Failure That Best Predict Clinical Failure In Prostate Cancer Patients Treated With External Beam Radiation Alone-A Multi-Institutional Pool...
  Horwitz, E.M.; Thames, H.D.; Kuban, D.A.; Levy, L.B.; Kupelian, P.A.; Martinez, A.A.; Michalski, J.M.; Pisansky T.M.; Sandler, H.M.; Shipley, W.U.; Zelefsky, M.J.; Han..., 45th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Salt Lake City, UT, 1/19/2003
• Definitions Of Biochemical Failure That Best Predict Clinical Failure In Prostate Cancer Patients Treated With External Beam Radiation Alone-A Multi-Institutional Pool...
  Horwitz, E.M.; Thames, H.D.; Kuban, D.A.; Levy, L.B.; Kupelian, P.A.; Martinez, A.A.; Michalski, J.M.; Pisansky T.M.; Sandler, H.M.; Shipley, W.U.; Zelefsky, M.J.; Han..., International Journal of Radiation Oncology Biology and Physics, 1/1/2003
• A new 3D non-uniform edema resolution model for prostate following permanent seed implant based upon serial radiography and MRI simulation.
  Horwitz, E.M.; Mitra, R.K.; Mah, D.; Hanlon, A.L.; Uzzo, R.G.; Pollack, A., 23rd Annual Meeting of the American Brachytherapy Society, Orlando, FL, 1/22/2002
• Does backdating change outcome when the ASTRO definition of biochemical control is used in patients with clinically localized prostate cancer treated with 3D conformal...
  Horwitz, E.M.; Uzzo, R.G.; Hanlon, A.L.; Greenberg, R.E.; Hanks, G.E.; Pollack, A., 44th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, New Orleans, LA, 1/6/2002
• A new 3D non-uniform edema resolution model for prostate following permanent seed implant based upon serial radiography and MRI simulation.
  Horwitz, E.M.; Mitra, R.K.; Uzzo, R.G.; Mah, D.; Hanlon, A.L.; Pollack, A., Proceedings of the American Brachytherapy Society, 1/1/2002
• Prostate cancer dose response to conformal radiotherapy.
  Pollack, A.; Hanlon, A.L.; Horwitz, E.M.; Hanks, G.E., Journal of Urology, 1/1/2002
• Join now to see all

Lectures

• Biochemical and Clinical Outcomes of Patients with Non-Metastatic Prostate Cancer Treated with Definitive Radiation Therapy or Surgery. 
  Atlanta, GA - 1/23/2015
• Newest Trends in Radiation Oncology for Prostate Cancer. 
  Royal Hospital, Muscat, Oman - 1/16/2014
• Invited lecture, "Education Session 305: External Beam Radiotherapy for Prostate Cancer: Dose, Volume, Fractionation." 
  San Francisco, CA - 1/16/2014
• Principles of Radiation Therapy: Radiotherapy & Proton Therapy for Urologic Malignancy. 
  Philadelphia, PA - 1/6/2014
• Invited lecture, "Education Session 308: External Beam Radiotherapy for Prostate Cancer: Dose, Volume, Fractionation." 
  Atlanta, GA - 1/24/2013
• Radiation treatment options for non-metastatic prostate cancer: From IMRT to brachytherapy. 
  Xi'an, China - 1/21/2013
• Brachytherapy for Prostate Cancer: State of the Art in 2013. 
  Philadelphia, PA - 1/4/2013
• Plenary Session: The Next 20 Years: An Update on Prostate Cancer Treatment and Trends. 
  Philadelphia, PA - 1/26/2011
• The ABS approach to quality assurance. 
  Houston, TX - 1/3/2011
• Moderator: "Plenary Session." 
  1/29/2010
• "Presidential Address: Quality Assurance-Education, Regulation and the Role of the ABS in the Practice of Brachytherapy in 2010." 
  Atlanta, GA - 1/28/2010
• RT Options and Outcomes for localized intermediate risk disease. 
  Sydney, Australia - 1/18/2010
• High Risk Localized disease: Should radiotherapy be first line? 
  Sydney, Australia - 1/18/2010
• High Risk Localized Disease. 
  Sydney, Australia - 1/18/2010
• Localized Disease (Low and Intermediate Risk). 
  Sydney, Australia - 1/18/2010
• Is There a Preferred Treatment for High Risk Prostate Carcinoma? The Case for IMRT and Androgen Deprivation Therapy. 
  New York, NY - 1/15/2010
• Invited lecture, "Education Session 205: External Beam Radiotherapy for Prostate Cancer: Dose, Volume, Fractionation." 
  San Diego, CA - 1/1/2010
• Presentation: "High Risk Prostate Cancer: IMRT +/-Androgen Deprivation Therapy." 
  Toronto, Ontario, Canada - 1/31/2009
• State of the Art Treatment of Prostate Cancer. 
  Philadelphia, PA - 1/22/2009
• Adjuvant Post-Operative Radiotherapy. 
  Bethesda, MD - 1/13/2009
• "Recent Advances In External Beam Radiotherapy" 
  Bethesda, MD - 1/13/2009
• Androgen Deprivation Therapy And Radiation: Who Gets It and For How Long? 
  Bethesda, MD - 1/13/2009
• Invited lecture, "Education Session 202: Radiotherapy for Favorable Risk Prostate Cancer: A Review of all the Options." 
  Chicago, IL - 1/2/2009
• Invited lecture, "Education Session 206: Radiotherapy for Favorable Risk Prostate Cancer: A Review of all the Options." 
  Boston, MA - 1/22/2008
• Plenary Session: State of the Art Brachytherapy in the Treatment of Prostate Cancer. 
  Philadelphia, PA - 1/22/2008
• Join now to see all